Our Summary

This research involves a study conducted on 16 patients with a specific type of ovarian tumor at the China-Japan Friendship Hospital. During surgery, a new device was used to completely enclose and isolate the tumor. This was done to measure factors like the size of the cyst, whether it ruptured during surgery, how long the surgery took, how much blood was lost, and how long patients stayed in the hospital after surgery. If the cyst could be removed without any fluid leakage, the surgery was considered successful.

The results showed that the surgeries were successful, with the average cyst size being 7.2 cm. In 75% of the cases, the cyst ruptured during surgery but without any fluid leakage. The surgeries took an average of 1.3 hours, with an average blood loss of 12.5 ml. All the cysts removed were non-cancerous and patients stayed in the hospital for about 2.4 days after surgery. No patients reported any symptoms or complaints related to inflammation of the peritoneum (the lining of the abdomen).

In conclusion, using this new device to isolate the tumor during minimally invasive ovarian cyst removal surgery was found to be safe and feasible. This is important to prevent cyst fluid from spreading in the body, which can lead to complications.

FAQs

  1. What is a totally enclosed protective device for tumor isolation?
  2. What were the results of the study on laparoscopic ovarian cystectomy using a totally enclosed protective device for tumor isolation?
  3. What are the benefits of using a totally enclosed protective device for tumor isolation during laparoscopic ovarian cystectomy?

Doctor’s Tip

A helpful tip a doctor might tell a patient about tumor resection is to follow all postoperative care instructions carefully, including taking prescribed medications, attending follow-up appointments, and avoiding strenuous activities. It is important to report any unusual symptoms or signs of infection to your healthcare provider promptly. Additionally, maintaining a healthy diet and lifestyle can aid in the healing process and reduce the risk of complications.

Suitable For

Patients with unilateral ovarian teratomas are typically recommended tumor resection using laparoscopic surgery with a totally enclosed protective device for tumor isolation. This approach has been shown to be safe and effective in preventing cystic fluid spillage, reducing the risk of incision site metastasis, and achieving successful surgery outcomes.

Timeline

  • Before tumor resection:
  1. Patient presents with symptoms such as pelvic pain, bloating, and abnormal bleeding.
  2. Patient undergoes imaging tests such as ultrasound or MRI to diagnose the tumor.
  3. Patient consults with a gynecologist or oncologist to discuss treatment options.
  4. Surgery is scheduled for tumor resection.
  5. Patient may undergo preoperative testing and preparation.
  • After tumor resection:
  1. Patient undergoes laparoscopic surgery with a totally enclosed protective device for tumor isolation.
  2. The cyst is resected intact without spillage, indicating successful surgery.
  3. Postoperative histology tests confirm a benign cyst.
  4. Patient experiences a mean length of stay of 2.4 days in the hospital.
  5. Patient recovers from surgery without any peritonitis-related symptoms or complaints.
  6. Follow-up appointments are scheduled to monitor recovery and ensure no recurrence of the tumor.

What to Ask Your Doctor

  1. What is the purpose of using a totally enclosed protective device for tumor isolation during laparoscopic ovarian cystectomy?
  2. How does the device help prevent spillage of cystic fluid during the surgery?
  3. What are the potential risks or complications associated with using this protective device?
  4. How does the use of the protective device affect the duration of the surgery and amount of blood loss?
  5. Are there any specific criteria or indications for using this protective device in ovarian tumor resection?
  6. What are the expected outcomes or success rates of using the protective device for tumor isolation in laparoscopic surgery?
  7. How does the use of the protective device impact the postoperative recovery and length of hospital stay for the patient?
  8. Are there any long-term benefits or implications of using this protective device in terms of recurrence or metastasis of the tumor?
  9. What follow-up care or monitoring is recommended after undergoing laparoscopic ovarian cystectomy with the protective device?
  10. Are there any alternative or additional treatment options that should be considered in conjunction with the use of the protective device for tumor isolation?

Reference

Authors: Yu H, Liang J, Liang H, Feng D, Ling B. Journal: Int J Gynaecol Obstet. 2023 Feb;160(2):588-593. doi: 10.1002/ijgo.14468. Epub 2022 Oct 8. PMID: 36114758